Automated synthesis of small molecules using chiral, non-racemic boronates
US-10752577-B2 · Aug 25, 2020 · US
US2017158614A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017158614-A1 |
| Application number | US-201615207196-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 11, 2016 |
| Priority date | Apr 27, 2011 |
| Publication date | Jun 8, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are methods for making and using chiral, non-racemic protected organoboronic acids, including pinene-derived iminodiacetic acid (PIDA) boronates, to direct and enable stereoselective synthesis of organic molecules. Also provided are methods for purifying PIDA boronates from solution. Also provided are methods for deprotection of boronic acids from their PIDA ligands. The purification and deprotection methods may be used in conjunction with methods for coupling or otherwise reacting boronic acids. Iterative cycles of deprotection, coupling, and purification can be performed to synthesize chiral, non-racemic compounds. The methods are suitable for use in an automated chemical synthesis process. Also provided is an automated small molecule synthesizer apparatus for performing automated stereoselective synthesis of chiral, non-racemic small molecules using iterative cycles of deprotection, coupling, and purification.
Opening claim text (preview).
1 - 4 . (canceled) 5 . A compound of formula (III) wherein: R* is a chiral group R 21 and R 22 are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, aralkyl, and heteroaralkyl; or R 21 and R 22 , taken together, form a 5-10-membered cycloalkyl or aromatic ring, or form a 5-10-membered heterocyclic or heteroaromatic ring comprising 1-3 heteroatoms independently selected from the group consisting of O, N, and S; R 23 is selected from the group consisting of hydrogen, alkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, aralkyl, and heteroaralkyl; R 1 and R 2 are both hydrogen or identically selected (C1-C3)alkyl; R 3 and R 4 are both hydrogen or identically selected (C1-C3)alkyl; and m is 0, 1, or 2, provided that the compound of formula (III) is not 6 . The compound of claim 5 , wherein R* is a chiral group of at least 90% enantiomeric excess. 7 . The compound of claim 5 , wherein R* is a chiral group of at least 95% enantiomeric excess. 8 . The compound of claim 5 , wherein R* is 9 . The compound of claim 8 , wherein R* is 10 . The compound of claim 8 , wherein R* is 11 . The compound of claim 5 , wherein R* is selected from the group consisting of 12 . The compound of claim 11 , wherein R* is selected from the group consisting of 13 . The compound of claim 11 , wherein R* is selected from the group consisting of 14 . The compound of claim 5 , wherein R 21 and R 22 , taken together, form a 5-10-membered cycloalkyl or aromatic ring, or form a 5-10-membered heterocyclic or heteroaromatic ring comprising 1-3 heteroatoms independently selected from the group consisting of O, N, and S. 15 . The compound of claim 14 , wherein R* is 16 . The compound of claim 15 , wherein R* is 17 . The compound of claim 15 , wherein R* is 18 . The compound of claim 14 , wherein R* is 19 . The compound of claim 18 , wherein R* is 20 . The compound of claim 18 , wherein R* is 21 . (canceled) 22 . The compound of claim 5 , wherein m is 0. 23 - 29 . (canceled) 30 . A compound of formula (IV) wherein: R 1 and R 2 are both hydrogen or identically selected (C1-C3)alkyl; R 30 is selected from the group consisting of hydrogen and (C1-C3)alkyl; and q is 1 or 2, provided that the compound of formula (IV) is not 31 . The compound of claim 30 , wherein the carbon atom marked “*” in formula (IV) is a chiral carbon atom of at least 90% enantiomeric excess. 32 - 164 . (canceled)
the bicyclo ring system containing seven carbon atoms · CPC title
Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
The ring being saturated · CPC title
having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.